Skip to main content
. 2011 Jul-Aug;4(4):122–127.

Table 1.

Patient characteristics (N = 162)

No. (%)
Gender Female 58 (35.8)
Male 104 (64.2)

Age (years) Median (range) 59 (20–76)

Performance status (ECOG) 0 122 (75.3)
1 17 (10.5)
2 5 (3.1)
3 8 (4.9)
4 10 (6.2)

Stage at diagnosis Locally advanced 58 (35.8)
Metastatic 104 (64.2)

Site of primary tumor Stomach 127 (78.4)
Lower esophageal 8 (4.9)
GEJ 27 (16.7)

Site of metastasis Liver 80 (49.4)
Lymph nodes 110 (67.9)
Peritoneum 69 (42.6)
Ovaries 23 (14.2)
Other 17 (10.5)

Histology Well differentiated 37 (22.8)
Moderately differentiated 39 (24.1)
Poorly differentiated 76 (46.9)
Unclassified 1 (0.6)
Undifferentiated 9 (5.6)

Presenting symptom(s) Weight loss 56 (34.6)
Anorexia 25 (15.4)
Pain 78 (48.1)
Reflux 72 (44.4)
Upper GI bleeding 17 (10.5)
Anemia 87 (53.7)
Nausea/vomiting 61 (37.7)
Gastric outlet obstruction 13 (8.0)
Dysphagia 17 (10.5)
None 7 (4.3)

Presence of HP at presentation Yes 128 (79.0)
No 13 (8.0)
Not available 21 (13.0)

Abbreviations: ECOG = Eastern Cooperative Oncology Group; GEJ = gastroesophageal junction; GI = gastrointestinal; HP = Helicobacter pylori infection.